ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000262202.3	Avagacestat	Bladder urothelial carcinoma	0.02782614	Resistant
ENSG00000262202.3	Avagacestat	Head and neck squamous cell carcinoma	0.0448053	Sensitive